Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|11|2|249-260
ISSN: 1389-4501
Source: Current Drug Targets, Vol.11, Iss.2, 2010-02, pp. : 249-260
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
What is the Optimal Treatment for Anemia in Inflammatory Bowel Disease?
Current Drug Delivery, Vol. 9, Iss. 4, 2012-07 ,pp. :
Emerging biotherapies for inflammatory bowel disease
Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. :
Mesalazine for the treatment of inflammatory bowel disease
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. :
Thiopurine Treatment in Inflammatory Bowel Disease
Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. :